Dynavax Technologies | DVAX - Stock


Dynavax Technologies reported $73.29M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.94B 22M Sep/2025
Adma Biologics USD 196.67M 5.21M Sep/2025
Amgen USD 6.22B 121M Dec/2025
AstraZeneca USD 6.59B 126M Sep/2025
Biogen USD 2.21B 64.9M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Dynavax Technologies USD 73.29M 2.4M Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Merck USD 6.44B 157M Sep/2025
Neurocrine Biosciences USD 69.3M 12.4M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Roche Holding CHF 7.6B 9M Jun/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
TG Therapeutics USD 146.95M 8.25M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025